Janus Henderson Group PLC Connect Biopharma Holdings LTD Transaction History

Janus Henderson Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $3.25 $492,702 - $2.86 Million	-879,826 Reduced 55.0%	720,000 $637,000
Q1 2022 May 16, 2022	BUY	$2.46 - $5.92 $2.89 Million - $6.95 Million	1,173,974 Added 275.68%	1,599,826 $4.81 Million
Q4 2021 Feb 14, 2022	BUY	$4.26 - $23.33 $95,394 - $522,428	22,393 Added 5.55%	425,852 $2.2 Million
Q3 2021 Nov 16, 2021	BUY	$18.12 - $28.5 $219,614 - $345,420	12,120 Added 3.1%	403,459 $9.57 Million
Q2 2021 Aug 16, 2021	SELL	$14.16 - $19.53 $1.18 Million - $1.63 Million	-83,661 Reduced 17.61%	391,339 $7.6 Million
Q1 2021 May 17, 2021	BUY	$15.9 - $18.61 $7.55 Million - $8.84 Million	475,000 New	475,000 $8.7 Million

3.05M

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $55M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.